Adenosine Deaminase-deficient Mice Generated Using a Two-stage Genetic Engineering Strategy Exhibit a Combined Immunodeficiency

This publication has 36 references indexed in Scilit:

• Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c
  Published by Elsevier ,1996
• Hepatic Dysfunction as a Complication of Adenosine Deaminase Deficiency
  New England Journal of Medicine, 1996
• Effects of (R)‐deoxycoformycin (pentostatin) on intrauterine nucleoside catabolism and embryo viability in the pregnant mouse
  Teratology, 1992
• Adenosine Deaminase and Thymocyte Maturation
  Scandinavian Journal of Immunology, 1991
• First trimester diagnosis of adenosine deaminase deficiency
  Prenatal Diagnosis, 1987
• Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes.
  Journal of Clinical Investigation, 1985
• Metabolic abnormalities of human adenosine deaminase deficiency reproduced in the mouse by 2′-deoxycoformycin, an adenosine deaminase inhibitor
  Clinical Immunology and Immunopathology, 1981
• Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease
  Cell, 1978
• The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency
  The Journal of Pediatrics, 1976
• ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITY
  The Lancet, 1972